VJHemOnc is committed to improving our service to you

MDS 2020 | MDS prognostic scores

VJHemOnc is committed to improving our service to you

Argiris Symeonidis

Argiris Symeonidis, MD, PhD, University of Patras, Patras, Greece, discusses the prognostic scoring system and independent variables used to assess the severity of a patient’s myelodysplastic syndrome (MDS). He also highlights some of the specific comorbid conditions such as cardiovascular disease, which cause non-leukemic death. This interview took place at the 2nd Regional Symposium on Myelodysplastic Syndromes (MDS 2020), held in Tel Aviv, Israel.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter